{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:09:06Z","timestamp":1791943746424,"version":"4.3.4"},"reference-count":36,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"7","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Global Oncology"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec><jats:title>PURPOSE<\/jats:title><jats:p> To provide expert guidance to clinicians and policymakers in three resource-constrained settings on diagnosis and staging of adult women with ovarian masses and treatment of patients with epithelial ovarian (including fallopian tube and primary peritoneal) cancer. <\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p> A multidisciplinary, multinational ASCO Expert Panel reviewed existing guidelines, conducted a modified ADAPTE process, and conducted a formal consensus process with additional experts. <\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p> Existing sets of guidelines from eight guideline developers were found and reviewed for resource-constrained settings; adapted recommendations from nine guidelines form the evidence base, informing two rounds of formal consensus; and all recommendations received \u2265 75% agreement. <\/jats:p><\/jats:sec><jats:sec><jats:title>RECOMMENDATIONS<\/jats:title><jats:p> Evaluation of adult symptomatic women in all settings includes symptom assessment, family history, and ultrasound and cancer antigen 125 serum tumor marker levels where feasible. In limited and enhanced settings, additional imaging may be requested. Diagnosis, staging, and\/or treatment involves surgery. Presurgical workup of every suspected ovarian cancer requires a metastatic workup. Only trained clinicians with logistical support should perform surgical staging; treatment requires histologic confirmation; surgical goal is staging disease and performing complete cytoreduction to no gross residual disease. In first-line therapy, platinum-based chemotherapy is recommended; in advanced stages, patients may receive neoadjuvant chemotherapy. After neoadjuvant chemotherapy, all patients should be evaluated for interval debulking surgery. Targeted therapy is not recommended in basic or limited settings. Specialized interventions are resource-dependent, for example, laparoscopy, fertility-sparing surgery, genetic testing, and targeted therapy. Multidisciplinary cancer care and palliative care should be offered. Additional information can be found at www.asco.org\/resource-stratified-guidelines . It is ASCO's view that health care providers and health care system decision makers should be guided by the recommendations for the highest stratum of resources available. The guideline is intended to complement but not replace local guidelines. <\/jats:p><\/jats:sec><jats:sec><jats:title\/><jats:p> [Media: see text] <\/jats:p><\/jats:sec>","DOI":"10.1200\/go.21.00085","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T19:59:55Z","timestamp":1624996795000},"page":"1032-1066","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":64,"title":["Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3656-6965","authenticated-orcid":false,"given":"Verna D.","family":"Vanderpuye","sequence":"first","affiliation":[{"name":"Korlebu Teaching Hospital, Accra, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Rene V.","family":"Clemenceau","sequence":"additional","affiliation":[{"name":"Hospital Angeles Del Pedregal, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1834-0551","authenticated-orcid":false,"given":"Sarah","family":"Temin","sequence":"additional","affiliation":[{"name":"American Society of Clinical Oncology, Alexandria, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5032-4503","authenticated-orcid":false,"given":"Zeba","family":"Aziz","sequence":"additional","affiliation":[{"name":"Hameed Latif Hospital, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Burke","sequence":"additional","affiliation":[{"name":"Stony Brook University Hospital, Stony Brook, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nixon Leonardo","family":"Cevallos","sequence":"additional","affiliation":[{"name":"Sociedad Lucha Contra Cancer Ecuador, Machala, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus T.","family":"Chuang","sequence":"additional","affiliation":[{"name":"Nuvance Health System, Danbury, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"Colgan","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela G.","family":"del Carmen","sequence":"additional","affiliation":[{"name":"LifeLabs, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7388-0243","authenticated-orcid":false,"given":"Keiichi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise C.","family":"Kohn","sequence":"additional","affiliation":[{"name":"Saitama Medical University International Medical Center, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Enrique","family":"Gonz\u00e1les Nogales","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda, La Paz, Bolivia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Okpoti","family":"Konney","sequence":"additional","affiliation":[{"name":"Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asima","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Chittaranjan National Cancer Institute, Kolkata, India"},{"name":"Northern Gynaecological Oncology Centre, Gateshead, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-7585","authenticated-orcid":false,"given":"Bishnu D.","family":"Paudel","sequence":"additional","affiliation":[{"name":"NAMS, Bir Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ic\u00f3","family":"T\u00f3th","sequence":"additional","affiliation":[{"name":"Mallow Flower Foundation, Dunaharaszti, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarikapan","family":"Wilailak","sequence":"additional","affiliation":[{"name":"Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-290X","authenticated-orcid":false,"given":"Rahel G.","family":"Ghebre","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School, Minneapolis, MN"},{"name":"St Paul's Hospital Millennium Medical School, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.12.016"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw306"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2018.05.005"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1075-122X.2006.00199.x"},{"key":"b8","volume-title":"Cancer: Disease Control Priorities","volume":"3","author":"Horton S","year":"2015","edition":"3"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2011-000172"},{"key":"b12","volume-title":"Management of Epithelial Ovarian Cancer","author":"Scottish Intercollegiate Guidelines Network (SIGN)","year":"2013"},{"key":"b13","volume-title":"Ovarian Cancer: Diagnosis, Treatment and Follow-up","author":"Vergote I","year":"2016"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.05.022"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.6907"},{"key":"b16","volume-title":"Systemic Therapy for Recurrent Ovarian Cancer","author":"Francis J","year":"2017"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-016-0985-x"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.04.016"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02960"},{"key":"b21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01924"},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.0489"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.19.00367"},{"key":"b24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.09.023"},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.0996"},{"key":"b26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808424"},{"key":"b27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03340220040030"},{"key":"b28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.1998.09783.x"},{"key":"b30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.560888"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.08.022"},{"key":"b32","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.55"},{"key":"b33","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000207"},{"key":"b34","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950315)75:6<1327::AID-CNCR2820750615>3.0.CO;2-P"},{"key":"b35","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00086-8"},{"key":"b36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01009"},{"key":"b37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104390"},{"key":"b38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103799"},{"key":"b39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.0632"},{"key":"b40","first-page":"1","volume":"4","author":"Osman H","year":"2018","journal-title":"J Glob Oncol"},{"key":"b41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.1474"},{"key":"b42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.2311"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO.21.00085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T18:49:39Z","timestamp":1658342979000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO.21.00085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1200\/GO.21.00085"],"URL":"https:\/\/doi.org\/10.1200\/go.21.00085","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"2021-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}